PT  - JOURNAL ARTICLE
AU  - Alba Pérez-Cataluña
AU  - Álvaro Chiner-Oms
AU  - Enric Cuevas-Ferrando
AU  - Azahara Díaz-Reolid
AU  - Irene Falcó
AU  - Walter Randazzo
AU  - Inés Girón-Guzmán
AU  - Ana Allende
AU  - María A. Bracho
AU  - Iñaki Comas
AU  - Gloria Sánchez
TI  - Detection Of Genomic Variants Of SARS-CoV-2 Circulating In Wastewater By High-Throughput Sequencing
AID  - 10.1101/2021.02.08.21251355
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.08.21251355
4099  - http://medrxiv.org/content/early/2021/02/10/2021.02.08.21251355.short
4100  - http://medrxiv.org/content/early/2021/02/10/2021.02.08.21251355.full
AB  - The use of SARS-CoV-2 metagenomics in wastewater can allow the detection of variants circulating at community level. After comparing with clinical databases, we identified three novel variants in the spike gene, and six new variants in the spike detected for the first time in Spain. We finally support the hypothesis that this approach allows the identification of unknown SARS-CoV-2 variants or detected at only low frequencies in clinical genomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by projects VIRIDIANA (AGL2017-82909/ AEI/FEDER, UE) funded by Spanish Ministry of Science, Innovation and Universities; CSIC (202070E101), and Generalitat Valenciana (Covid_19-SCI). EC-F is recipient of a predoctoral contract from the MICINN, Call 2018.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable, no human samples have been used in this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData availability under demand